Canada· CA-DIN-02381702
ACT RIZATRIPTAN
A rizatriptan product containing rizatriptan (rizatriptan benzoate), registered in Canada by TEVA CANADA LIMITED. The same ATC class is registered in 16 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Rizatriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC04 (rizatriptan), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Rizatriptan · ATC N02CC04
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of rizatriptan costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.25 in France to $10.95 in Switzerland — a ×8.8 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rizatriptan · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$10.95
- ES Spain$5.01
- IT Italy$2.91
- FR France$1.25
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- RIZATRIPTAN (RIZATRIPTAN BENZOATE)
- Manufacturer
- TEVA CANADA LIMITED
- Country
- Canada (CA)
- ATC code
- N02CC04
- ATC class
- Rizatriptan
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for rizatriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rizatriptan · interactions on record
106 records
- 11 severe
- 6 moderate
- 88 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rizatriptan in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMaxalt 10mg tabletsSigma Pharmaceuticals Plc
- SwedenRizatriptan Ebb 10 mg TablettEbb Medical AB
- SpainMAXALT 10 mg COMPRIMIDOSOrganon Salud S.L.
- SwitzerlandMaxalt 10 mg, TablettenOrganon GmbH
- ItalyMAXALTORGANON ITALIA S.R.L.
- FranceMAXALT 10 mg, compriméORGANON FRANCE
- NetherlandsMaxalt 10 mg, tablettenN.V. Organon
- IcelandMaxalt SmeltN.V. Organon*
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Germany · Rizatriptan Al, Rizatriptan Glenmark
- Denmark · Rizasmelt, Rizatriptan ”stada”
- Spain · Rizatriptán Flas Kern Pharma, Rizatriptán Max Viatris
- Finland · Rizastad, Rizatriptan Stada
- France · Rizatriptan Eg, Rizatriptan Viatris
- United Kingdom (Northern Ireland) · Rizatriptan Glenmark Pharmaceuticals Europe, Rizatriptan Macleods Pharma Uk
- Croatia · Emalt
- Italy · Rizatriptan Mylan Generics, Rizatriptan Sandoz
- Netherlands · Rizatriptan Sandoz, Rizatriptan Viatris
- Sweden · Rizasmelt, Rizatriptan Glenmark
- Slovakia · Rizatriptan Sandoz, Rizatriptan Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a4e18269-9c9b-4744-a81f-d8a89e4a126f GET /v1/drugs/a4e18269-9c9b-4744-a81f-d8a89e4a126f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02381702",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N02CC04",
"schedule": [
"Prescription"
],
"drug_code": "86756",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"RIZATRIPTAN (RIZATRIPTAN BENZOATE)"
],
"product_categorization": null
}See everything about rizatriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.